Quantcast

Latest Clinical trial Stories

2014-06-30 23:01:16

The Mesothelioma Applied Research Foundation (Meso Foundation) unveiled today its expanded Travel Grant program, which provides patients in need of financial help for travel expenses to consult with a specialist, or to participate in a clinical trial away from home. Alexandria, VA (PRWEB) June 30, 2014 The Mesothelioma Applied Research Foundation (Meso Foundation) announced today the expansion of its ‘Travel Grant’ program for mesothelioma patients. The program, which was created...

2014-06-30 16:26:45

Phase 3 Study Meets Primary Endpoint and Six Secondary Endpoints Across Multiple Disease-Related Abnormalities LEXINGTON, Mass., June 30, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, announced today that the global, randomized, double-blind, placebo-controlled Phase 3 ARISE trial of sebelipase alfa in 66 children and adults with lysosomal acid lipase deficiency (LAL...

2014-06-30 16:26:40

SANTA ROSA, Calif., June 30, 2014 /PRNewswire/ -- Ruthigen, Inc. (NASDAQ: RTGN) today reported financial results for its fourth quarter and fiscal year ended March 31, 2014. "We are poised to commence patient enrollment in the initial phase of our first human clinical trial using RUT58-60 in July 2014, and plan to complete our Phase 1/2 clinical trial in less than nine months," said Hoji Alimi, Chairman, CEO and CSO of Ruthigen. "We believe that the completion of our recent initial public...

2014-06-30 12:31:55

BUFFALO, N.Y. and SEOUL, South Korea, June 30, 2014 /PRNewswire/ -- Hanmi Pharmaceuticals announces a positive study on Oraxol® use in a Phase I/II clinical proof-of-concept study (Study HM-OXL-201) of Oraxol - an oral form of the approved drug paclitaxel, with HM30181, a highly potent and selective, P-glycoprotein inhibitor of the gastro-intestinal tract. The study, entitled "A phase I-II clinical trial to determine the recommended dose and to assess the efficacy, safety and...

2014-06-30 08:31:06

DUBLIN, June 30. 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/kzl2xt/clinical_trial) has announced the addition of the "2014 Report on the International Clinical Trial Management System Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. Globally, the CTMS...

2014-06-30 08:30:01

LUGANO, Switzerland, June 30, 2014 /PRNewswire/ -- Exclusive distribution and licensing agreement signed for the commercialization of Helsinn's compound currently in development for the treatment of cancer anorexia-cachexia syndrome in non-small cell lung cancer (NSCLC) patients Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilac....

2014-06-27 21:43:11

BMJ-British Medical Journal US regulator has taken 84 sponsors/investigators/institutions to task over 7 years Failure to protect patient safety and poor record keeping were among the most common violations picked up by the US regulator in the running of clinical trials over a period of seven years, reveals a study published online in the Journal of Medical Ethics. The study authors reviewed the content of 84 first warning letters issued by the United States Food and Drug...

2014-06-27 08:25:47

LONDON and ROCHESTER, New York, June 27, 2014 /PRNewswire/ -- Commercial and Operational Alliance to Provide Clinical Trials Industry With Global Capabilities and a Full Range of Therapeutic Areas and Modality Expertise IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today said they have signed an Alliance Framework Agreement and...

2014-06-27 04:21:21

ROCHESTER, N.Y. and LONDON, June 27, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, today said they have signed an Alliance Framework Agreement and Master Subcontractor Agreement previously announced as an agreement in principle on March 7, 2014. This alliance will provide the clinical trials industry with global operational capabilities and a full range of...

2014-06-26 23:10:35

David Turner to discuss mobile solutions for clinical trials at the Digital Health Zone App Bar on June 26, 2014 San Diego, CA (PRWEB) June 26, 2014 Parallel 6 makes its introduction as a clinical trial mobile solution at this week’s 2014 BIO International Convention. Parallel 6 CEO David Turner will speak on June 26, 2014 demonstrating the mobile enterprise platform Captive Reach and its influence on the future of clinical trials. “At Parallel 6, our Captive Reach platform and...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related